CRIS Current Research Information System

GUGLIELMO, ALBA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
AS - Asia 2.012
NA - Nord America 1.373
EU - Europa 1.012
AF - Africa 99
SA - Sud America 98
OC - Oceania 2
Totale 4.596
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 1.350
VN - Vietnam 555
SG - Singapore 543
CN - Cina 475
IT - Italia 283
SE - Svezia 154
DE - Germania 137
HK - Hong Kong 133
GB - Regno Unito 91
IN - India 82
KR - Corea 74
BR - Brasile 67
NL - Olanda 56
RU - Federazione Russa 50
FR - Francia 48
IE - Irlanda 41
AT - Austria 33
CI - Costa d'Avorio 33
ZA - Sudafrica 29
JP - Giappone 28
FI - Finlandia 25
AR - Argentina 19
ID - Indonesia 16
TG - Togo 16
BG - Bulgaria 15
PH - Filippine 15
CH - Svizzera 14
JO - Giordania 13
ES - Italia 11
MX - Messico 11
PL - Polonia 11
TR - Turchia 11
CA - Canada 10
IQ - Iraq 10
BD - Bangladesh 9
TH - Thailandia 9
UA - Ucraina 9
HR - Croazia 8
PK - Pakistan 7
SC - Seychelles 7
TW - Taiwan 7
EC - Ecuador 6
LT - Lituania 6
NG - Nigeria 5
AE - Emirati Arabi Uniti 4
GR - Grecia 4
UZ - Uzbekistan 4
DK - Danimarca 3
IR - Iran 3
PY - Paraguay 3
SA - Arabia Saudita 3
AU - Australia 2
AZ - Azerbaigian 2
ET - Etiopia 2
IL - Israele 2
MA - Marocco 2
RO - Romania 2
RS - Serbia 2
SY - Repubblica araba siriana 2
TN - Tunisia 2
AL - Albania 1
BA - Bosnia-Erzegovina 1
BE - Belgio 1
CL - Cile 1
CO - Colombia 1
DO - Repubblica Dominicana 1
DZ - Algeria 1
EE - Estonia 1
EG - Egitto 1
HU - Ungheria 1
JM - Giamaica 1
KZ - Kazakistan 1
LB - Libano 1
MD - Moldavia 1
MT - Malta 1
MY - Malesia 1
NP - Nepal 1
OM - Oman 1
PE - Perù 1
PT - Portogallo 1
RE - Reunion 1
SK - Slovacchia (Repubblica Slovacca) 1
Totale 4.596
Salva come PNG Salva come JPEG
Città #
Singapore 383
Chandler 173
Hefei 164
Ashburn 162
Ho Chi Minh City 137
Hong Kong 125
San Jose 117
Hanoi 110
Santa Clara 91
Dong Ket 74
Bologna 71
Southend 69
Seoul 66
Fairfield 55
Beijing 51
Dublin 41
Princeton 40
Abidjan 33
Boardman 33
Los Angeles 32
New York 30
Vienna 30
Houston 28
Lauterbourg 28
Dallas 27
Tokyo 25
Redmond 24
Wilmington 23
Council Bluffs 22
Johannesburg 22
Milan 22
Haiphong 20
Seattle 19
Munich 17
Da Nang 16
Lomé 16
Woodbridge 16
Cambridge 15
Helsinki 15
Sofia 15
Bengaluru 14
Frankfurt am Main 14
Rome 14
Amman 13
Berlin 13
Turin 13
Buffalo 12
Redondo Beach 12
Ann Arbor 11
Bremen 11
Des Moines 11
Bern 9
Florence 9
Jakarta 9
Quận Bình Thạnh 8
San Diego 8
Verona 8
Warsaw 8
Delhi 7
Kuban 7
Nuremberg 7
Piacenza 7
Amsterdam 6
Biên Hòa 6
Guangzhou 6
London 6
São Paulo 6
Turku 6
Abeokuta 5
Bắc Giang 5
Bắc Ninh 5
Hyderabad 5
Hải Dương 5
Nanjing 5
Pune 5
Redwood City 5
Taranto 5
Thái Nguyên 5
Yubileyny 5
Bangkok 4
Can Tho 4
Chongqing 4
Hangzhou 4
Jinan 4
Lappeenranta 4
Manchester 4
Mexico City 4
Phoenix 4
The Dalles 4
Thái Bình 4
Tongling 4
Venice 4
Aragona 3
Baghdad 3
Catania 3
Cesena 3
Chicago 3
City of London 3
Fuzhou 3
Ha Long 3
Totale 2.849
Salva come PNG Salva come JPEG
Nome #
Acral skin eruption observed during SARS-CoV-2 pandemic: possible keratolysis exfoliativa with red palms and soles 219
Biologics and small molecules treatment for moderate-to-severe atopic dermatitis patients with comorbid conditions and special populations: an Italian perspective 218
Herpes zoster in COVID-19-positive patients 202
Disseminate Recurrent Folliculitis and Hidradenitis Suppurativa Are Associated Conditions: Results From a Retrospective Study of 131 Patients With Down Syndrome and a Cohort of 12,351 Pediatric Controls 189
Cutaneous squamous cell carcinoma progression during imiquimod treatment 176
PTEN Hamartoma Tumor Syndrome: Skin Manifestations and Insights Into Their Molecular Pathogenesis 166
Cutaneous adverse-events in patients treated with Ibrutinib 162
Chilblain lesions after COVID-19 mRNA vaccine 161
Clinical and trichoscopic features in 18 cases of Folliculotropic Mycosis Fungoides with scalp involvement 159
New insights into alopecia areata during COVID-19 pandemic: When infection or vaccination could play a role 152
Primary cutaneous CD4+ small/medium T-cell lymphoproliferative disorder nodule successfully treated with laser Co2 ablation: a case report and literature review 150
Bexarotene as maintenance treatment after therapies other than skin-directed therapy in advanced-stage mycosis fungoides: a pilot study 150
Biological therapy in patients with psoriasis: What we know about the effects on renal function 149
A Narrative Review of the State of the Art of CCR4-Based Therapies in Cutaneous T-Cell Lymphomas: Focus on Mogamulizumab and Future Treatments 147
Primary Cutaneous CD4+ Small/Medium T-Cell Lymphoproliferative Disorders (SMPLPD), demographical, clinical, therapeutic and prognostic aspects: a retrospective monocentric analysis 146
A Case of Bullous Rash Apparently Triggered by Meningococcal and Rotavirus Vaccines in an Infant: Focus on Infantile Bullous Pemphigoid 132
Erythroderma with brentuximab vedotin (skin side effects in mycosis fungoides) 132
Erythrodermie mit Brentuximab‐Vedotin (Hautnebenwirkungen bei Mycosis fungoides) 132
Major cluster of paediatric ‘true’ primary chilblains during the COVID-19 pandemic: a consequence of lifestyle changes due to lockdown 125
Dermoscopy of chilblain-like lesions during the COVID-19 outbreak: A multicenter study on 10 patients 125
Generalized granuloma annulare-like eruption secondary to acute Epstein–Barr virus infection 114
Violaceous Papules and Plaques on the Fingers during COVID-19: A Quiz 107
Chilblains in a child with confirmed SARS-CoV-2 infection: a red flag for late-onset skin manifestation in previously infected individuals 102
Immune-Mediated Dermatoses in Patients with Haematological Malignancies: A Comprehensive Review 101
The microenvironment’s role in mycosis fungoides and sézary syndrome: From progression to therapeutic implications 98
Immune Check Point Inhibitors in Primary Cutaneous T-Cell Lymphomas: Biologic Rationale, Clinical Results and Future Perspectives 97
PD-1 and PD-L1 expression in mycosis fungoides and Sézary Syndrome 94
Terra firma-forme dermatosis: a systematic review 92
'Colouring' wipes phenomenon: a peculiar skin pigmentation induced by ascorbic acid observed during lockdown 83
Estimating the incidence of COVID-19 skin manifestations on the general population in a territorial setting 82
The red half-moon nail sign: a novel manifestation of coronavirus infection. 76
New insights into the oncological risk in heart transplant recipients: could skin tumors represent a marker of increased risk for solid neoplasm? 67
Second neoplasm in cutaneous T-cell lymphoma patients: a marker of worse prognosis? 55
OX40–OX40L Axis in Cutaneous T-Cell Lymphomas: Pathogenic, Prognostic, and Potential Therapeutic Perspectives 45
Phenotypical Markers, Molecular Mutations, and Immune Microenvironment as Targets for New Treatments in Patients with Mycosis Fungoides and/or Sézary Syndrome 45
Non-Melanoma Skin Cancer in Transplant Recipients: A Single-Centre Retrospective Cohort Study on the Role of Transplant Type, Immunosuppressive Exposure, and Tumor Subtypes 42
Chlormethine gel effectiveness as second-line treatment in mycosis fungoides: a single-centre retrospective study 39
Interleukin‐13 inhibition and cancer risk: reply to Tang and Chen 38
Vulvar vitiligo and lichen sclerosus in children: A clinical challenge 37
Effectiveness and safety of baricitinib in severe alopecia areata: 48-week results 36
Oral pigmentation in children: a diagnostic challenge 31
Mogamulizumab-induced alopecia. Multicentric case series: Clinical, trichoscopic and histological characterization. 28
Skin toxicities related to Bruton tyrosine kinase inhibitors: an updated review 26
Totale 4.727
Salva come PNG Salva come JPEG
Categoria #
all - tutte 14.009
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 14.009
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021106 0 0 0 0 0 0 0 0 0 10 19 77
2021/2022471 43 9 20 57 32 20 7 44 28 38 109 64
2022/2023590 48 78 44 77 54 61 23 48 79 17 37 24
2023/2024215 14 40 16 27 18 49 7 16 2 6 1 19
2024/2025944 34 114 79 89 118 35 80 44 7 69 76 199
2025/20262.203 213 301 195 160 229 122 169 120 510 184 0 0
Totale 4.727